JSC Grindeks

JSC Grindeks

JSC Grindeks is the leading pharmaceutical company in the Baltic States.

Its main fields of action are: research, development, manufacturing and sale of original products, generics and active pharmaceutical ingredients.

The company consists of four subsidiary companies in countries: Latvia, Estonia and Russia, as well as representative offices in 13 countries.

Kalendorius:

The company plans to publish its:

  • non-audited interim financial statement for the 12-month period of 2019 on 28 February 2020;
  • non-audited interim financial statement for the 3-month period of 2020 on 29 May 2020;
  • non-audited interim financial statement for the 6-month period of 2020 on 27 August 2020;
  • non-audited interim financial statement for the 9-month period of 2020 on 26 November 2020.

The audited separate and consolidated financial statement of Grindeks JSC of 2019 is scheduled for 30 April 2020.


 

Kompanijos puslapis

Forumas

Facebook Komentarai
Patinka turinys? Palaikykite turinio kokybę Apie Investavimą Paprastai Patreon!
%d bloggers like this: